These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37954480)

  • 21. Changing Patterns in Epidemiology of Brucellosis in the South of Iran (2015-2020): Based on Cochrane-Armitage Trend Test.
    Delam H; Keshtkaran Z; Rezaei B; Soufi O; Bazrafshan MR
    Ann Glob Health; 2022; 88(1):11. PubMed ID: 35223430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer in Ardabil province in the north-west of Iran: an epidemiological study.
    Fouladi N; Pourfarzi F; Amani F; Ali-Mohammadi H; Lotf I; Mazaheri E
    Asian Pac J Cancer Prev; 2012; 13(4):1543-5. PubMed ID: 22799363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatio-temporal distribution analysis of zoonotic cutaneous leishmaniasis in Qom Province, Iran.
    Salimi M; Jesri N; Javanbakht M; Farahani LZ; Shirzadi MR; Saghafipour A
    J Parasit Dis; 2018 Dec; 42(4):570-576. PubMed ID: 30538355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological Characteristics and Trend in the Incidence of Human Brucellosis in Iran from 2009 to 2017.
    Norouzinezhad F; Erfani H; Norouzinejad A; Ghaffari F; Kaveh F
    J Res Health Sci; 2021 Dec; 21(4):e00535. PubMed ID: 36511231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spatiotemporal distribution of human brucellosis in mainland China from 2007-2016.
    Liang P; Zhao Y; Zhao J; Pan D; Guo Z
    BMC Infect Dis; 2020 Mar; 20(1):249. PubMed ID: 32216760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological, Risk Factors, Clinical, and Laboratory Features of Brucellosis in the Southwest of Iran within 2009-2015.
    Nabavi M; Hatami H; Jamaliarand H
    Int J Prev Med; 2019; 10():108. PubMed ID: 31360355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological features of brucellosis and factors affecting its treatment failure and relapse in Qom Province, Iran.
    Mohammadbeigi A; Saghafipour A; Hamta A; Khazaei S; Maghsoudi A; Shams S
    Ghana Med J; 2021 Sep; 55(3):206-212. PubMed ID: 35950176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological features of human brucellosis in central Iran, 2006-2011.
    Zeinalian Dastjerdi M; Fadaei Nobari R; Ramazanpour J
    Public Health; 2012 Dec; 126(12):1058-62. PubMed ID: 22884862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geo-epidemiological reporting and spatial clustering of the 10 most prevalent cancers in Iran.
    Babaee E; Roshandel G; Olfatifar M; Tehrani-Banihashemi A; Ashaari A; Nojomi M
    Geospat Health; 2021 May; 16(1):. PubMed ID: 34000792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of Brucellosis among General Population in Famenin City, Western Iran in 2016: The Famenin Brucellosis Cohort Study.
    Keramat F; Karami M; Alikhani MY; Bashirian S; Moghimbeigi A; Hashemi SH; Mamani M; Shivapoor Z; Bosilkovski M; Adabi M
    Arch Iran Med; 2020 Nov; 23(11):749-756. PubMed ID: 33220691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Situational Analysis of Visceral Leishmaniasis in the Most Important Endemic Area of the Disease in Iran.
    Moradi-Asl E; Hanafi-Bojd AA; Rassi Y; Vatandoost H; Mohebali M; Yaghoobi-Ershadi MR; Habibzadeh S; Hazrati S; Rafizadeh S
    J Arthropod Borne Dis; 2017 Dec; 11(4):482-496. PubMed ID: 29367925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in the Epidemiology of Brucellosis Cases in Iran during the Last Decade.
    Zeinali M; Doosti S; Amiri B; Gouya MM; Godwin GN
    Iran J Public Health; 2022 Dec; 51(12):2791-2798. PubMed ID: 36742247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Spatial Distribution of Cancer Incidence in Fars Province: A GIS-Based Analysis of Cancer Registry Data.
    Goli A; Oroei M; Jalalpour M; Faramarzi H; Askarian M
    Int J Prev Med; 2013 Oct; 4(10):1122-30. PubMed ID: 24319551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spatial and temporal characteristics of human brucellosis, from 2004 to 2012 in Shandong province].
    Yang L; Kou Z; Bi Z; Zhang L; Zheng L; Zhao Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Aug; 35(8):925-9. PubMed ID: 25376684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of human brucellosis in Nahavand county, Hamadan Province, western Iran: an 8-year (2010-2017) registry-based analysis.
    Khazaei S; Solgi M; Goodarzi S; Khazaei L; Salehi I; Jenabi E
    Asian Biomed (Res Rev News); 2020 Aug; 14(4):151-158. PubMed ID: 37551387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing the spatial and temporal distribution of human brucellosis in Azerbaijan (1995 - 2009) using spatial and spatio-temporal statistics.
    Abdullayev R; Kracalik I; Ismayilova R; Ustun N; Talibzade A; Blackburn JK
    BMC Infect Dis; 2012 Aug; 12():185. PubMed ID: 22873196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GIS-based risk mapping of cutaneous leishmaniasis: a survey in an endemic area of Central Iran.
    Maracy MR; Jaffary F; Ebrahimi A; Sokhanvari F; Heidari A; Sharifian-Koupaiee H; Fadaei R; Ramazanpour J; Moazeni M
    Environ Sci Pollut Res Int; 2021 Nov; 28(41):57470-57485. PubMed ID: 34089455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comprehensive Database and Geographical Distribution Model of Vectors and Vector Borne Diseases in Ardabil Province, Borderline of Iran and Azerbaijan Republic 2001-2018.
    Adham D; Vatandoost H; Moradi-Asl E
    J Arthropod Borne Dis; 2021 Sep; 15(3):287-299. PubMed ID: 36578994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of Human Hydatidosis in Ardabil Province, North-West of Iran.
    Heidari Z; Mohammadi-Ghalehbin B; Alizadeh Z; Molaei S; Dogaheh HP; Mirzanejad-Asl H
    Iran J Parasitol; 2021; 16(4):593-600. PubMed ID: 35082888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to improve the human brucellosis surveillance system in Kurdistan Province, Iran: reduce the delay in the diagnosis time.
    Olfatifar M; Hosseini SM; Shokri P; Khodakarim S; Khadembashi N; Rahimi Pordanjani S
    Epidemiol Health; 2020; 42():e2020058. PubMed ID: 32777881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.